Northwest & Ethical Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Northwest & Ethical Investments’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,501	Closed	-$692K	–	374
2017 Q3	$692K	Buy	7,501 +4,929	+192%	+$474K	0.04%	307
2017 Q2	$291K	Sell	2,572 -775	-23%	-$86.6K	0.02%	324
2017 Q1	$335K	Hold	3,347	–	–	0.02%	338
2016 Q4	$360K	Buy	3,347 +777	+30%	+$90.8K	0.02%	328
2016 Q3	$320K	Hold	2,570	–	–	0.02%	300
2016 Q2	$273K	Buy	+2,570	New	+$298K	0.02%	211
2015 Q4	–	Sell	-3,080	Closed	-$277K	–	224
2015 Q3	$277K	Buy	3,080 +2,073	+206%	+$219K	0.02%	193
2015 Q2	$116K	Buy	+1,007	New	+$106K	0.01%	213

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Northwest & Ethical Investments's CBPO Position: Q4 2017 in Review

Northwest & Ethical Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 7,501 shares — an estimated $692K sold.

Northwest & Ethical Investments first reported a position in CBPO in Q2 2015 and held it in 8 quarters. The position peaked at $692K in Q3 2017. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

Northwest & Ethical Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
Northwest & Ethical Investments sold 7,501 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $692K.
Northwest & Ethical Investments first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 8 quarters.
Northwest & Ethical Investments's China Biologic Products Holdings, Inc. position peaked at $692K in Q3 2017.
93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Northwest & Ethical Investments's 13F filing for Q4 2017, filed 8 Jul 2025.